U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug

Analysis-FTC settlement could shelter Amgen from US price cuts, taxes

Amgen settles with the FTC over $28 billion deal

Amgen gets US FTC's go-ahead for $27.8 billion Horizon deal

US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics

California, other states join FTC bid to block Amgen deal

FTC effort to stop Amgen's Horizon takeover faces uphill fight

U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents

US FTC sues to block Amgen's $27.8 billion deal for Horizon Therapeutics

FTC Commissioners yet to meet on Amgen-Horizon deal - CNBC

FTC to block Amgen's deal to acquire Horizon Therapeutics - source